Table 4.
Prevalence of stage, variable, and effect in studies analyzed.
| AR (n = 4) % |
VR (n = 20) % |
AR/VR (n = 4) % |
TOTAL (n = 28) % |
|
|---|---|---|---|---|
| Stage | ||||
| Development and testing | 0.0 | 20.0 | 25.0 | 17.9 |
| Results | 50.0 | 30.0 | 50.0 | 35.7 |
| Evaluated | 50.0 | 50.0 | 25.0 | 46.4 |
| Variable | ||||
| Performance | 100.0 | 50.0 | 50.0 | 57.1 |
| Engagement | 0.0 | 10.0 | 25.0 | 10.7 |
| Performance and engagement | 0.0 | 25.0 | 0.0 | 17.9 |
| Effectiveness | 0.0 | 5.0 | 25.0 | 7.1 |
| No evaluated | 0.0 | 10.0 | 0.0 | 7.1 |
| Effect | ||||
| Positive | 25.0 | 40.0 | 25.0 | 35.7 |
| Increased | 50.0 | 60.0 | 50.0 | 57.1 |
| Neutral | 25.0 | 0.0 | 0.0 | 3.6 |
| No evaluated | 0.0 | 0.0 | 25.0 | 3.6 |